Johanna Rantala

Pathology of Breast and Ovarian Cancers among <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers: Results from the Consortium of Investigators of Modifiers of <i>BRCA1</i> / <i>2</i> (CIMBA)

Nasim Mavaddat, Daniel Barrowdale, Irene L. Andrulis et al. · Cancer Epidemiology Biomarkers & Prevention · 2012 · 668 citations · Full text

Medicine, Genetics, Oncology +15

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

Stig E. Bojesen, Karen A. Pooley, Sharon E. Johnatty et al. · Nature Genetics · 2013 · 540 citations · Full text

Life Sciences, Genetics, Molecular Genetics +14

Association of Type and Location of<i>BRCA1</i>and<i>BRCA2</i>Mutations With Risk of Breast and Ovarian Cancer

Timothy R. Rebbeck, Nandita Mitra, Fei Wan et al. · JAMA · 2015 · 509 citations · Full text

Medicine, Genetics, Oncology +17

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer

Roger L. Milne, Karoline Kuchenbaecker, Kyriaki Michailidou et al. · Nature Genetics · 2017 · 471 citations · Full text

Medicine, Genetics, Oncology +12

Common variants on chromosome 5p12 confer susceptibility to estrogen receptor–positive breast cancer

Simon Stacey, Andrei Manolescu, Patrick Sulem et al. · Nature Genetics · 2008 · 463 citations

Life Sciences, Genetics, Molecular Genetics +17